181 related articles for article (PubMed ID: 32522977)
1. Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma.
Weidner P; Söhn M; Schroeder T; Helm L; Hauber V; Gutting T; Betge J; Röcken C; Rohrbacher FN; Pattabiraman VR; Bode JW; Seger R; Saar D; Nunes-Alves A; Wade RC; Ebert MPA; Burgermeister E
Oncogenesis; 2020 Jun; 9(6):59. PubMed ID: 32522977
[TBL] [Abstract][Full Text] [Related]
2. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
[TBL] [Abstract][Full Text] [Related]
3. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
[TBL] [Abstract][Full Text] [Related]
4. Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α).
Singh S; Simpson RL; Bennett RG
J Biol Chem; 2015 Jan; 290(2):950-9. PubMed ID: 25389293
[TBL] [Abstract][Full Text] [Related]
5. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
[TBL] [Abstract][Full Text] [Related]
6. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.
Burgermeister E; Schnoebelen A; Flament A; Benz J; Stihle M; Gsell B; Rufer A; Ruf A; Kuhn B; Märki HP; Mizrahi J; Sebokova E; Niesor E; Meyer M
Mol Endocrinol; 2006 Apr; 20(4):809-30. PubMed ID: 16373399
[TBL] [Abstract][Full Text] [Related]
7. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
8. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
Huang WC; Chio CC; Chi KH; Wu HM; Lin WW
Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2.
Chen L; Necela BM; Su W; Yanagisawa M; Anastasiadis PZ; Fields AP; Thompson EA
J Biol Chem; 2006 Aug; 281(34):24575-87. PubMed ID: 16815847
[TBL] [Abstract][Full Text] [Related]
10. PPARγ signaling and emerging opportunities for improved therapeutics.
Wang S; Dougherty EJ; Danner RL
Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.
Lu X; Bijli KM; Ramirez A; Murphy TC; Kleinhenz J; Hart CM
Free Radic Biol Med; 2013 Oct; 63():151-60. PubMed ID: 23684777
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis.
Kaplan JM; Hake PW; Denenberg A; Nowell M; Piraino G; Zingarelli B
Mol Med; 2010; 16(11-12):491-7. PubMed ID: 20809049
[TBL] [Abstract][Full Text] [Related]
13. Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9.
Mochizuki Y; Majerus PW
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9768-73. PubMed ID: 12890864
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
Ishii N; Matsumura T; Kinoshita H; Fukuda K; Motoshima H; Senokuchi T; Nakao S; Tsutsumi A; Kim-Mitsuyama S; Kawada T; Takeya M; Miyamura N; Nishikawa T; Araki E
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1598-605. PubMed ID: 20508203
[TBL] [Abstract][Full Text] [Related]
15. Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer.
Weidner P; Söhn M; Gutting T; Friedrich T; Gaiser T; Magdeburg J; Kienle P; Ruh H; Hopf C; Behrens HM; Röcken C; Hanoch T; Seger R; Ebert MP; Burgermeister E
Oncotarget; 2016 Aug; 7(31):50490-50506. PubMed ID: 27409167
[TBL] [Abstract][Full Text] [Related]
16. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
Shiraki T; Kodama TS; Jingami H; Kamiya N
Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
[TBL] [Abstract][Full Text] [Related]
17. Rational design of stapled helical peptides as antidiabetic PPARγ antagonists to target coactivator site by decreasing unfavorable entropy penalty instead of increasing favorable enthalpy contribution.
Zhang Y; Wang J; Li W; Guo Y
Eur Biophys J; 2022 Dec; 51(7-8):535-543. PubMed ID: 36057906
[TBL] [Abstract][Full Text] [Related]
18. Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor γ Coactivator-1α by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological Conditions.
Collier JB; Whitaker RM; Eblen ST; Schnellmann RG
J Biol Chem; 2016 Dec; 291(52):26850-26859. PubMed ID: 27875304
[TBL] [Abstract][Full Text] [Related]
19. A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.
Choi SS; Kim ES; Koh M; Lee SJ; Lim D; Yang YR; Jang HJ; Seo KA; Min SH; Lee IH; Park SB; Suh PG; Choi JH
J Biol Chem; 2014 Sep; 289(38):26618-26629. PubMed ID: 25100724
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
